throbber
Product Information
`Healthcare
`
`DOWCORNING
`
`Dow Corning® 360 Medical Fluid
`
`FEATURES & BENEFITS
`• Available in five standard
`viscosities
`• High water
`repellency/hydrophobicity
`• Good stability over a broad range
`of temperatures
`• Excellent lubricating
`characteristics
`• Low surface tension
`• Low order of toxicity and skin
`sensitization
`• Tested according to and complies
`with all National Formulaiy (NF)
`requirements for Dimethicone and
`European Pharmacopeia (EP)
`requirements for Dimeticone or
`Silicone Oil Used as a Lubricant,
`depending on viscosity
`
`COMPOSITION
`• Clear, colorless
`polydimethylsiloxane fluid
`
`Hydrophobic lubricant for medical devices
`
`APPLICATIONS
`• Silicone fluid for lubrication and siliconization of glass, metals, plastics and
`rubber.
`
`TYPICAL PROPERTIES
`Specification Writers: These values are not intended for use in preparing
`specifications. Please contact your local Dow Corning sales office or your Global
`Dow Corning Connection before writing specifications on this product.
`
`CTM1
`
`ASTM2
`
`Property
`
`Unit
`
`Result
`
`Visual appearance
`
`Clear as water
`
`0176
`
`0005
`
`0044
`
`D1209
`
`Color (APHA)
`
`D70 Specific gravity at 25°C
`
`D1217
`
`20 est
`
`100 est
`
`350 cSt, 1000 cSt
`
`< 15
`
`0.951
`
`0.967
`
`0.972
`
`1.4018
`
`1.4032
`
`1.4042
`
`1.4046
`
`1.4047
`
`0002
`
`D1218 Refractive index
`
`20 est
`
`100 est
`
`350 est
`
`1000 est
`
`12,500 est
`
`0004
`
`D445 Viscosity at 25°C
`
`D21 62
`
`D2515
`
`20 est
`
`%of nominal
`
`± 10
`
`100 and 350 cSt
`
`%of nominal
`
`±5
`
`0050
`
`D1084 Viscosity at 25°C
`
`D4287
`
`1000 est
`
`12,500 est
`
`0051
`
`D664
`
`Acid number
`
`0079
`
`D974
`
`Infrared identification
`
`%of nominal
`
`%of nominal
`
`±5
`
`±5
`
`BPB
`(Bromophenyl
`Blue)
`
`< 0.02
`
`Matches reference
`spectrum for specific
`viscosity
`
`1CTM: Corporate Test Method, copies ofCTMs are available on request.
`2ASTM: American Society for Testing and Materials
`
`NOVITC(US)00000788
`
`Novartis Exhibit 2152.001
`Regeneron v. Novartis, IPR2021-00816
`
`

`

`DESCRIPTION
`Dow Corning® 360 Medical Fluid is a
`clear, colorless polydimethylsiloxane
`liquid that is available in five
`standard viscosities.
`
`IMPORTANT NOTICE
`Dow Corning neither represents nor
`tests this material for specific medical
`device or pharmaceutical
`applications. Purchaser is fully
`responsible to determine end-use
`suitability.
`
`REGULATORY AND
`PHARMACOPEIAL
`STATUS
`Dow Corning 360 Medical Fluid is
`not to be used as a new drug or new
`device as defined by regulatory
`authorities (e.g., the U.S. Food and
`Drug Administration) until the user
`has obtained appropriate approval
`from those regulatory authorities.
`This fluid is not approved by the
`FDA for tissue augmentation and
`Dow Corning does not support this
`use.
`
`Each lot of Dow Corning 360
`Medical Fluid is tested and complies
`with the current monograph
`requirements for Dimethicone NF,
`Dimeticone EP, or Silicone Oil Used
`as a Lubricant EP, depending on the
`fluid viscosity.
`
`A certification of these test results is
`available upon request.
`
`Dow Corning also maintains a Drug
`Master File with the U.S. FDA and
`holds a Certificate of Suitability to
`support European registrations.
`
`MANUFACTURING
`ENVIRONMENT
`Dow Corning 360 Medical Fluid is
`manufactured, tested and packaged
`under strict quality control guidelines
`at the Healthcare Industries Materials
`Site (HIMS). The HIMS (Hemlock,
`Mich.) is dedicated to the production
`of silicone materials for healthcare
`applications. It is registered with the
`U.S. Food and Drug Administration
`
`20 15. August 10
`Form No. 51-03740-01
`
`(FDA) as a drug establishment (CFN
`1816403). The site quality system for
`active pharmaceutical ingredients
`(APis) is in compliance with current
`Good Manufacturing Practices for
`Bulk Pharmaceutical Products. The
`site is also ISO registered by BSI.
`
`HOWTOUSE1
`Dow Corning 360 Medical Fluid can
`be applied directly to surfaces by
`techniques such as dipping, spraying
`or wiping to provide a lubricious
`and/or hydrophobic coating.
`
`When a very thin film of fluid is
`desired, Dow Corning 360 Medical
`Fluid can be diluted to the desired
`silicone fluid concentration (such as
`0.1 to 2%) in a nonpolar solvent. After
`Dow Corning 360 Medical Fluid has
`been applied, allow sufficient time to
`permit the solvent to evaporate.
`Solvents that can be used with
`Dow Corning 360 Medical Fluid are
`discussed in the Compatibility section.
`
`Although Dow Corning 360 Medical
`Fluid possesses excellent lubricant
`characteristics, the fluid may not
`provide satisfactory lubrication when
`used in situations such as metal
`against metal. On temperature
`resistant materials, such as glass,
`ceramic and metal, this fluid film can
`be heated to provide a more durable
`hydrophobic film.
`
`Dow Corning 360 Medical Fluid can
`be applied to silicone elastomers for
`temporary lubricity. Before exposing a
`silicone elastomer to a silicone fluid,
`the user should evaluate the effect of
`the exposure on the performance.
`
`Sterilization
`Sterilization of the bulk fluid is not
`recommended. If sterilization is
`necessary for a given application, the
`sterilization process should be done on
`the treated article.
`
`Steam autoclaving sterilization of bulk
`fluid by steam autoclaving is not
`recommended. Excess water diffuses
`into the fluid, causing the fluid to
`become hazy. Thin films of fluid may
`
`be satisfactorily sterilized by this
`method.
`
`Gamma irradiation the exl)osure of
`polydimethylsiloxane fluids, such as
`Dow Corning 360 Medical Fluid, to
`25 kGy of cobalt-60 radiation has the
`effect of introducing small levels of
`cross-linking into the fluid and is
`observed as an increase in fluid
`viscosity. This effect is most
`noticeable in the higher-viscosity
`fluids (e.g. , 12,500 cSt). As with any
`exposure of a product to radiation, one
`should evaluate product performance
`after exposure to determine if such
`treatment has detrimental effects.
`
`Dry heat sterilization of bulk fluid is
`not recommended. Thin films of fluid
`may be satisfactorily sterilized by this
`method. The temperature of the fluid
`should not exceed 200°C because
`small amounts of formaldehyde may
`be generated.
`
`COMPATIBILITY
`Dow Corning 360 Medical Fluid is
`soluble in all proportions in nonpolar
`solvents:
`
`• Aliphatic hydrocarbon (e.g.,
`hexane, heptane, mineral spirits)
`• Aromatic hydrocarbon (e.g.,
`toluene, xylene)
`
`Several ozone-safe, volatile organic
`compound (VOC)-exempt solvents are
`compatible with Dow Corning 360
`Medical Fluid:
`
`• Dow Corning® Q7-9180 Silicone
`Fluids
`• Dow Corning® OS-10 Fluid,
`Dow Corning® OS-20 Fluid,
`Dow Corning® OS-30 Fluid
`• Vertrel®2 XSi Cleaning Agent
`Lenium®3 DF
`•
`
`1For additional information on uses, toxicity,
`analysis and methods of applying
`polydimethylsiloxane fluids in parenteral
`applications, read Technical Report No. 12,
`Siliconization of Parenteral Drug Packaging
`Components, Jou rnal of Parenteral Science
`and Technology, Volume 42, No. 4S, 1988 .
`2Vertrel is a registered trademarlc The Chemours
`Company.
`3Lenium is a registered trademark of Vantage
`Specialties Inc.
`
`Dow Corning is a registered trademark of Dow Coming Corporation
`We help y ou invent th efuh1re is a trademark of Dow Corning Corporation
`XIAMETER is a registered trademark of Dow Coming Corporation
`© 2002 - 201 5 Dow Coming Corporation. All rights reserved.
`
`2
`
`NOVITC(US)00000789
`
`Novartis Exhibit 2152.002
`Regeneron v. Novartis, IPR2021-00816
`
`

`

`Solvents selected from this list are
`frequently used to dilute
`Dow Corning 360 Medical Fluid as
`a means of applying the fluid to
`articles by dipping or spraying. As
`the polarity of the solvent
`increases, the solubility of the
`silicone fluid decreases.
`
`For example, Dow Corning 360
`Medical Fluid is, for all practical
`purposes, insoluble in glycerin,
`ethylene glycol, stearyl alcohol,
`methanol, ethanol and water.
`Limited solubility ofless than 0.5%
`may be obtained for 20 and 100 cSt
`fluid in anhydrous isopropanol.
`Lower- viscosity (molecular
`weight) Dow Corning 360 Medical
`Fluid will tend to have a slightly
`increased solubility in the more
`polar solvents. Moderate solubility
`(approximately 10%) is obtained in
`some ethers (e.g., ethyl ether,
`esters; amyl acetate and ketones;
`methyl ethyl ketone).
`
`BLENDING
`Although the fluid is available in a
`number of standard viscosities,
`occasionally an application calls for a
`fluid of an intermediate viscosity.
`Blending of different viscosities of
`Dow Corning 360 Medical Fluid
`permits any desired viscosity between
`20 and 12,500 cSt.
`
`The blending chart (Figure 1) is a
`guideline for preparing intermediate
`fluid viscosities. To use the blending
`chart:
`
`1. Draw a line between two points
`one on the left-hand scale
`representing the higher-viscosity
`fluid available, and one on the
`right, the lower-viscosity fluid;
`2. Draw another line horizontally
`across the chart at the desired
`viscosity rating;
`3. Draw a third line vertically
`through the intersection of the
`first two lines;
`4. Read from the top and bottom
`scales the proportions of the
`available fluids to blend to obtain
`the desired viscosity.
`
`20 15. August 10
`Form No. 51-03740-01
`
`Figure 1: Blending chart for Dow Corning 360 Medical Fluid
`
`l'erv..:ntby w,:igh1. ,YfHi gh,·1~\/is-·o·;j;y Flu id
`
`iuo.oon --<......,~ ........ ---'-----i----i---....;...-..,J.._-i..._...L--J wn,ooo
`
`HJO
`
`'!O
`
`80
`
`70
`
`61>
`
`5!?
`
`40
`
`30
`
`:.'U
`
`J tl
`
`0
`
`12;500 Y
`:.'i
`IO.GOO
`
`l.OGO
`
`35iJ
`
`Hi !'--.--..........,,..........---,-~---~-~-~--.............J iO
`l()()
`
`Accuracy is increased by blending the
`two fluids that immediately bracket
`the desired viscosity. If a very
`accurate blend is required, it may be
`necessary to adjust the viscosity of the
`mixture by a second blending.
`
`The example shown in Figure 1 is as
`follows: 150 cSt fluid is desired. The
`standard viscosities immediately
`bracketing 150 cSt are 100 and 350
`cSt. Draw line A connecting 350 cSt
`on the left-hand scale with 100 cSt on
`the right-hand scale. Draw line B
`horizontally at the desired viscosity of
`150. Atthe point of intersection, AB,
`draw vertical line C. The proportion of
`100 cSt viscosity fluid (67%) is read
`on the bottom scale; the proportion of
`350 cSt viscosity fluid (33%) is read
`on the top scale.
`
`HANDLING
`PRECAUTIONS
`PRODUCT SAFETY
`INFORMATION REQUIRED FOR
`SAFE USE IS NOT INCLUDED IN
`TIDS DOCUMENT. BEFORE
`HANDLING, READ PRODUCT
`AND SAFETY DATA SHEETS
`
`AND CONTAINER LABELS FOR
`SAFE USE, PHYSICAL AND
`HEALTH HAZARD
`INFORMATION. THE SAFETY
`DATA SHEET IS AVAILABLE ON
`THE DOW CORNING WEBSITE
`AT DOWCORNING.COM, OR
`FROM YOUR DOW CORNING
`SALES APPLICATION
`ENGINEER, OR DISTRIBUTOR,
`OR BY CALLING
`DOW CORNING CUSTOMER
`SERVICE.
`
`USABLE LIFE AND
`STORAGE
`When stored in original, unopened
`containers this product has a usable
`life of 60 months from the date of
`production.
`
`PACKAGING
`INFORMATION
`Dow Corning 360 Medical Fluid is
`available in five standard viscosities:
`20, 100, 350, 1000 and 12,500 cSt.
`The material is supplied in 0.45, 18,
`and 200 kg (1, 40, and 440 lbs)
`containers, net weight.
`
`Dow Corning is a registered trademark of Dow Coming Corporation
`We help y ou invent th efuh1re is a trademark of Dow Corning Corporation
`XIAMETER is a registered trademark of Dow Coming Corporation
`© 2002 - 201 5 Dow Coming Corporation. All rights reserved.
`
`3
`
`NOVITC(US)00000790
`
`Novartis Exhibit 2152.003
`Regeneron v. Novartis, IPR2021-00816
`
`

`

`SHIPPING LIMITATIONS
`None
`
`ORDERING
`Dow Corning requires a signed
`affidavit detailing information on the
`intended use of Dow Corning 360
`Medical Fluid before acting upon a
`request for a sample or sales order.
`
`To obtain additional information or to
`place an order, contact your local
`Dow Corning representative.
`
`HEALTH AND
`ENVIRONMENTAL
`INFORMATION
`To support customers in their product
`safety needs, Dow Corning has an
`extensive Product Stewardship
`organization and a team of Product
`Safety and Regulatory Compliance
`(PS&RC) specialists available in each
`area.
`
`For further information, please see our
`website, dowcorning.com or consult
`your local Dow Corning
`representative.
`
`LIMITED WARRANTY
`INFORMATION - PLEASE
`READ CAREFULLY
`The information contained herein is
`offered in good faith and is believed to
`be accurate. However, because
`conditions and methods of use of our
`products are beyond our control, this
`information should not be used in
`substitution for customer's tests to
`ensure that our products are safe,
`effective, and fully satisfactory for the
`intended end use. Suggestions of use
`shall not be taken as inducements to
`infringe any patent.
`
`Dow Corning' s sole warranty is that
`our products will meet the sales
`specifications in effect at the time of
`shipment.
`
`Your exclusive remedy for breach of
`such warranty is limited to refund of
`purchase price or replacement of any
`product shown to be other than as
`warranted.
`
`201 5. August 10
`Form No. 51-03740-01
`
`TO THE FULLEST EXTENT
`PERMITTED BY APPLICABLE
`LAW, DOW CORNING
`SPECIFICALLY DISCLAIMS
`ANY OTHER EXPRESS OR
`IMPLIED WARRANTY OF
`FITNESS FOR AP ARTICULAR
`PURPOSE OR
`MERCHANTABILITY.
`
`DOW CORNING DISCLAIMS
`LIABILITY FOR ANY
`INCIDENTAL OR
`CONSEQUENTIAL DAMAGES.
`
`We help you invent the future. TM
`
`dowcoming.com
`
`Dow Corning is a registered trademark of Dow Coming Corporation
`We help y ou invent the fu h1re is a trademark of Dow Corning Corporation
`XIAMETER is a registered trademark of Dow Coming Corporation
`© 2002 - 201 5 Dow Coming Corporation. All rights reserved.
`
`4
`
`NOVITC(US)00000791
`
`Novartis Exhibit 2152.004
`Regeneron v. Novartis, IPR2021-00816
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket